ArticleInfectious diseases and therapy2018

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

Olayemi Osiyemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.